E
RXDX

Ergoteles’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Ergoteles’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8,791
Closed -$208K – 1705
2021
Q3 		$208K Buy
+8,791
New +$208K 0.01% 972